Abdominal and retroperitoneal sarcomas are rare tumors originating from connective tissues in the body like muscle, fat, fibrous tissue, and blood vessels.
Surgery is the primary treatment option for these tumors, and complete surgical resection is the only potential cure. Typically, these tumors can be large at detection, and the management of abdominal and retroperitoneal tumors can be difficult. In addition to surgery, chemotherapy, radiation therapy, and new target therapies are the applied treatment modalities.
The surgical management of abdominal and retroperitoneal sarcoma is evolving. In this special issue we want to highlight advances in the surgical management of abdominal and retroperitoneal sarcomas, including new surgical technology, minimal invasive surgery, and personalized surgery. Furthermore, we would like to address controversies in the surgical management of abdominal and retroperitoneal surgery, including, aggressive surgical approaches, compartment resection, resection of disseminated tumors, resection of recurrent disease, and the value of (neo)adjuvant chemo- and radiation therapy.
The aim of this special issue is to summarize advances and controversies in the surgical treatment of abdominal and retroperitoneal sarcomas, and to point out areas for further research.
We welcome manuscripts on minimal invasive surgery (endoscopic, laparoscopic and robot-assisted surgery), aggressive surgical approaches and compartment resection, personalized surgery, and image-guided surgery. This also includes manuscripts on resection of disseminated tumors and recurrent disease. Furthermore, results of surgical management combined with (neo)adjuvant treatment with chemotherapy, radiation therapy, or other new treatment modalities are of special interest for this issue.
Abdominal and retroperitoneal sarcomas are rare tumors originating from connective tissues in the body like muscle, fat, fibrous tissue, and blood vessels.
Surgery is the primary treatment option for these tumors, and complete surgical resection is the only potential cure. Typically, these tumors can be large at detection, and the management of abdominal and retroperitoneal tumors can be difficult. In addition to surgery, chemotherapy, radiation therapy, and new target therapies are the applied treatment modalities.
The surgical management of abdominal and retroperitoneal sarcoma is evolving. In this special issue we want to highlight advances in the surgical management of abdominal and retroperitoneal sarcomas, including new surgical technology, minimal invasive surgery, and personalized surgery. Furthermore, we would like to address controversies in the surgical management of abdominal and retroperitoneal surgery, including, aggressive surgical approaches, compartment resection, resection of disseminated tumors, resection of recurrent disease, and the value of (neo)adjuvant chemo- and radiation therapy.
The aim of this special issue is to summarize advances and controversies in the surgical treatment of abdominal and retroperitoneal sarcomas, and to point out areas for further research.
We welcome manuscripts on minimal invasive surgery (endoscopic, laparoscopic and robot-assisted surgery), aggressive surgical approaches and compartment resection, personalized surgery, and image-guided surgery. This also includes manuscripts on resection of disseminated tumors and recurrent disease. Furthermore, results of surgical management combined with (neo)adjuvant treatment with chemotherapy, radiation therapy, or other new treatment modalities are of special interest for this issue.